In order to explore the contribution of NF-κB regulated gene expression in astrocytes to ALS onset and progression, we developed transgenic mice expressing a super-repressor of NF-κB specifically in GFAP-positive astrocytes (GFAP-IκBαAA). The gene discussed is NFKB1; the disease is amyotrophic lateral sclerosis.